Cyclizine, sold under a number of brand names, is a medication used to treat and prevent nausea, vomiting and dizziness due to motion sickness or vertigo. It may also be used for nausea after general anaesthesia or that which developed from opioid use.
The global Cyclizine market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Cyclizine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cyclizine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Cyclizine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Oral
Injection
Segment by Application
Migraine
Motion Sickness
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Amoun Pharmaceutical
Glaxosmithkline
Pharmascript Limited
Advanz Pharma
Teva
P and D Pharmaceuticals
Wabosan Arzneimittel
Aspen Pharmacare
Amco
Aft Pharmaceuticals
Be-Tabs Pharmaceuticals
Wockhardt UK
The global Cyclizine market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Cyclizine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cyclizine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Cyclizine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Oral
Injection
Segment by Application
Migraine
Motion Sickness
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Amoun Pharmaceutical
Glaxosmithkline
Pharmascript Limited
Advanz Pharma
Teva
P and D Pharmaceuticals
Wabosan Arzneimittel
Aspen Pharmacare
Amco
Aft Pharmaceuticals
Be-Tabs Pharmaceuticals
Wockhardt UK
1 Cyclizine Market Overview
1.1 Product Overview and Scope of Cyclizine
1.2 Cyclizine Segment by Type
1.2.1 Global Cyclizine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oral
1.2.3 Injection
1.3 Cyclizine Segment by Application
1.3.1 Cyclizine Sales Comparison by Application: (2021-2027)
1.3.2 Migraine
1.3.3 Motion Sickness
1.4 Global Cyclizine Market Size Estimates and Forecasts
1.4.1 Global Cyclizine Revenue 2016-2027
1.4.2 Global Cyclizine Sales 2016-2027
1.4.3 Cyclizine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Cyclizine Market Competition by Manufacturers
2.1 Global Cyclizine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Cyclizine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Cyclizine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Cyclizine Manufacturing Sites, Area Served, Product Type
2.5 Cyclizine Market Competitive Situation and Trends
2.5.1 Cyclizine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cyclizine Players Market Share by Revenue
2.5.3 Global Cyclizine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cyclizine Retrospective Market Scenario by Region
3.1 Global Cyclizine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Cyclizine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Cyclizine Market Facts & Figures by Country
3.3.1 North America Cyclizine Sales by Country
3.3.2 North America Cyclizine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cyclizine Market Facts & Figures by Country
3.4.1 Europe Cyclizine Sales by Country
3.4.2 Europe Cyclizine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cyclizine Market Facts & Figures by Region
3.5.1 Asia Pacific Cyclizine Sales by Region
3.5.2 Asia Pacific Cyclizine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cyclizine Market Facts & Figures by Country
3.6.1 Latin America Cyclizine Sales by Country
3.6.2 Latin America Cyclizine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cyclizine Market Facts & Figures by Country
3.7.1 Middle East and Africa Cyclizine Sales by Country
3.7.2 Middle East and Africa Cyclizine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cyclizine Historic Market Analysis by Type
4.1 Global Cyclizine Sales Market Share by Type (2016-2021)
4.2 Global Cyclizine Revenue Market Share by Type (2016-2021)
4.3 Global Cyclizine Price by Type (2016-2021)
5 Global Cyclizine Historic Market Analysis by Application
5.1 Global Cyclizine Sales Market Share by Application (2016-2021)
5.2 Global Cyclizine Revenue Market Share by Application (2016-2021)
5.3 Global Cyclizine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Amoun Pharmaceutical
6.1.1 Amoun Pharmaceutical Corporation Information
6.1.2 Amoun Pharmaceutical Description and Business Overview
6.1.3 Amoun Pharmaceutical Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Amoun Pharmaceutical Product Portfolio
6.1.5 Amoun Pharmaceutical Recent Developments/Updates
6.2 Glaxosmithkline
6.2.1 Glaxosmithkline Corporation Information
6.2.2 Glaxosmithkline Description and Business Overview
6.2.3 Glaxosmithkline Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Glaxosmithkline Product Portfolio
6.2.5 Glaxosmithkline Recent Developments/Updates
6.3 Pharmascript Limited
6.3.1 Pharmascript Limited Corporation Information
6.3.2 Pharmascript Limited Description and Business Overview
6.3.3 Pharmascript Limited Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pharmascript Limited Product Portfolio
6.3.5 Pharmascript Limited Recent Developments/Updates
6.4 Advanz Pharma
6.4.1 Advanz Pharma Corporation Information
6.4.2 Advanz Pharma Description and Business Overview
6.4.3 Advanz Pharma Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Advanz Pharma Product Portfolio
6.4.5 Advanz Pharma Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 P and D Pharmaceuticals
6.6.1 P and D Pharmaceuticals Corporation Information
6.6.2 P and D Pharmaceuticals Description and Business Overview
6.6.3 P and D Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 P and D Pharmaceuticals Product Portfolio
6.6.5 P and D Pharmaceuticals Recent Developments/Updates
6.7 Wabosan Arzneimittel
6.6.1 Wabosan Arzneimittel Corporation Information
6.6.2 Wabosan Arzneimittel Description and Business Overview
6.6.3 Wabosan Arzneimittel Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Wabosan Arzneimittel Product Portfolio
6.7.5 Wabosan Arzneimittel Recent Developments/Updates
6.8 Aspen Pharmacare
6.8.1 Aspen Pharmacare Corporation Information
6.8.2 Aspen Pharmacare Description and Business Overview
6.8.3 Aspen Pharmacare Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Aspen Pharmacare Product Portfolio
6.8.5 Aspen Pharmacare Recent Developments/Updates
6.9 Amco
6.9.1 Amco Corporation Information
6.9.2 Amco Description and Business Overview
6.9.3 Amco Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Amco Product Portfolio
6.9.5 Amco Recent Developments/Updates
6.10 Aft Pharmaceuticals
6.10.1 Aft Pharmaceuticals Corporation Information
6.10.2 Aft Pharmaceuticals Description and Business Overview
6.10.3 Aft Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Aft Pharmaceuticals Product Portfolio
6.10.5 Aft Pharmaceuticals Recent Developments/Updates
6.11 Be-Tabs Pharmaceuticals
6.11.1 Be-Tabs Pharmaceuticals Corporation Information
6.11.2 Be-Tabs Pharmaceuticals Cyclizine Description and Business Overview
6.11.3 Be-Tabs Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Be-Tabs Pharmaceuticals Product Portfolio
6.11.5 Be-Tabs Pharmaceuticals Recent Developments/Updates
6.12 Wockhardt UK
6.12.1 Wockhardt UK Corporation Information
6.12.2 Wockhardt UK Cyclizine Description and Business Overview
6.12.3 Wockhardt UK Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Wockhardt UK Product Portfolio
6.12.5 Wockhardt UK Recent Developments/Updates
7 Cyclizine Manufacturing Cost Analysis
7.1 Cyclizine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cyclizine
7.4 Cyclizine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cyclizine Distributors List
8.3 Cyclizine Customers
9 Cyclizine Market Dynamics
9.1 Cyclizine Industry Trends
9.2 Cyclizine Growth Drivers
9.3 Cyclizine Market Challenges
9.4 Cyclizine Market Restraints
10 Global Market Forecast
10.1 Cyclizine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cyclizine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Cyclizine by Type (2022-2027)
10.2 Cyclizine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cyclizine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Cyclizine by Application (2022-2027)
10.3 Cyclizine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cyclizine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Cyclizine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Cyclizine
1.2 Cyclizine Segment by Type
1.2.1 Global Cyclizine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oral
1.2.3 Injection
1.3 Cyclizine Segment by Application
1.3.1 Cyclizine Sales Comparison by Application: (2021-2027)
1.3.2 Migraine
1.3.3 Motion Sickness
1.4 Global Cyclizine Market Size Estimates and Forecasts
1.4.1 Global Cyclizine Revenue 2016-2027
1.4.2 Global Cyclizine Sales 2016-2027
1.4.3 Cyclizine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Cyclizine Market Competition by Manufacturers
2.1 Global Cyclizine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Cyclizine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Cyclizine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Cyclizine Manufacturing Sites, Area Served, Product Type
2.5 Cyclizine Market Competitive Situation and Trends
2.5.1 Cyclizine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cyclizine Players Market Share by Revenue
2.5.3 Global Cyclizine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cyclizine Retrospective Market Scenario by Region
3.1 Global Cyclizine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Cyclizine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Cyclizine Market Facts & Figures by Country
3.3.1 North America Cyclizine Sales by Country
3.3.2 North America Cyclizine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cyclizine Market Facts & Figures by Country
3.4.1 Europe Cyclizine Sales by Country
3.4.2 Europe Cyclizine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cyclizine Market Facts & Figures by Region
3.5.1 Asia Pacific Cyclizine Sales by Region
3.5.2 Asia Pacific Cyclizine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cyclizine Market Facts & Figures by Country
3.6.1 Latin America Cyclizine Sales by Country
3.6.2 Latin America Cyclizine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cyclizine Market Facts & Figures by Country
3.7.1 Middle East and Africa Cyclizine Sales by Country
3.7.2 Middle East and Africa Cyclizine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cyclizine Historic Market Analysis by Type
4.1 Global Cyclizine Sales Market Share by Type (2016-2021)
4.2 Global Cyclizine Revenue Market Share by Type (2016-2021)
4.3 Global Cyclizine Price by Type (2016-2021)
5 Global Cyclizine Historic Market Analysis by Application
5.1 Global Cyclizine Sales Market Share by Application (2016-2021)
5.2 Global Cyclizine Revenue Market Share by Application (2016-2021)
5.3 Global Cyclizine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Amoun Pharmaceutical
6.1.1 Amoun Pharmaceutical Corporation Information
6.1.2 Amoun Pharmaceutical Description and Business Overview
6.1.3 Amoun Pharmaceutical Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Amoun Pharmaceutical Product Portfolio
6.1.5 Amoun Pharmaceutical Recent Developments/Updates
6.2 Glaxosmithkline
6.2.1 Glaxosmithkline Corporation Information
6.2.2 Glaxosmithkline Description and Business Overview
6.2.3 Glaxosmithkline Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Glaxosmithkline Product Portfolio
6.2.5 Glaxosmithkline Recent Developments/Updates
6.3 Pharmascript Limited
6.3.1 Pharmascript Limited Corporation Information
6.3.2 Pharmascript Limited Description and Business Overview
6.3.3 Pharmascript Limited Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pharmascript Limited Product Portfolio
6.3.5 Pharmascript Limited Recent Developments/Updates
6.4 Advanz Pharma
6.4.1 Advanz Pharma Corporation Information
6.4.2 Advanz Pharma Description and Business Overview
6.4.3 Advanz Pharma Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Advanz Pharma Product Portfolio
6.4.5 Advanz Pharma Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 P and D Pharmaceuticals
6.6.1 P and D Pharmaceuticals Corporation Information
6.6.2 P and D Pharmaceuticals Description and Business Overview
6.6.3 P and D Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 P and D Pharmaceuticals Product Portfolio
6.6.5 P and D Pharmaceuticals Recent Developments/Updates
6.7 Wabosan Arzneimittel
6.6.1 Wabosan Arzneimittel Corporation Information
6.6.2 Wabosan Arzneimittel Description and Business Overview
6.6.3 Wabosan Arzneimittel Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Wabosan Arzneimittel Product Portfolio
6.7.5 Wabosan Arzneimittel Recent Developments/Updates
6.8 Aspen Pharmacare
6.8.1 Aspen Pharmacare Corporation Information
6.8.2 Aspen Pharmacare Description and Business Overview
6.8.3 Aspen Pharmacare Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Aspen Pharmacare Product Portfolio
6.8.5 Aspen Pharmacare Recent Developments/Updates
6.9 Amco
6.9.1 Amco Corporation Information
6.9.2 Amco Description and Business Overview
6.9.3 Amco Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Amco Product Portfolio
6.9.5 Amco Recent Developments/Updates
6.10 Aft Pharmaceuticals
6.10.1 Aft Pharmaceuticals Corporation Information
6.10.2 Aft Pharmaceuticals Description and Business Overview
6.10.3 Aft Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Aft Pharmaceuticals Product Portfolio
6.10.5 Aft Pharmaceuticals Recent Developments/Updates
6.11 Be-Tabs Pharmaceuticals
6.11.1 Be-Tabs Pharmaceuticals Corporation Information
6.11.2 Be-Tabs Pharmaceuticals Cyclizine Description and Business Overview
6.11.3 Be-Tabs Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Be-Tabs Pharmaceuticals Product Portfolio
6.11.5 Be-Tabs Pharmaceuticals Recent Developments/Updates
6.12 Wockhardt UK
6.12.1 Wockhardt UK Corporation Information
6.12.2 Wockhardt UK Cyclizine Description and Business Overview
6.12.3 Wockhardt UK Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Wockhardt UK Product Portfolio
6.12.5 Wockhardt UK Recent Developments/Updates
7 Cyclizine Manufacturing Cost Analysis
7.1 Cyclizine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cyclizine
7.4 Cyclizine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cyclizine Distributors List
8.3 Cyclizine Customers
9 Cyclizine Market Dynamics
9.1 Cyclizine Industry Trends
9.2 Cyclizine Growth Drivers
9.3 Cyclizine Market Challenges
9.4 Cyclizine Market Restraints
10 Global Market Forecast
10.1 Cyclizine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cyclizine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Cyclizine by Type (2022-2027)
10.2 Cyclizine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cyclizine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Cyclizine by Application (2022-2027)
10.3 Cyclizine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cyclizine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Cyclizine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
